Senior insider sale
PRESIDENT AND CEO at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$61.9K
18.89K shares
What this filing means
AUERBACH ALAN H plans to sell 18.89K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $61.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2024ACC: 0001610717-24-000385
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
18.89K
Shares to sell
$61.9K
Approx. market value
192.98K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Unit Grant
Compensation for Services Rendered
3/15/2024
6.58KRestricted Stock Unit Grant
Compensation for Services Rendered
2/10/2023
186.40KTotal acquired192.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2024 | Restricted Stock Unit Grant Compensation for Services Rendered | 6.58K | — |
2/10/2023 | Restricted Stock Unit Grant Compensation for Services Rendered | 186.40K | — |
| Total | 192.98K | ||
Planned & Completed Dispositions1
NASDAQGSPlanned
Units to sell
18.89K
Market value
$61.9K
7/2/2024
Total
Units
18.89K
Value
$61.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/2/2024 | 18.89K | $61.9K | NASDAQGS | Planned |
| Total | 18.89K | $61.9K | ||